Literature DB >> 2789232

Phenotypic and functional analysis at the clonal level of infiltrating T lymphocytes in papillary carcinoma of the thyroid: prevalence of cytolytic T cells with natural killer-like or lymphokine-activated killer activity.

M Bagnasco1, D Venuti, F Paolieri, G Torre, S Ferrini, G W Canonica.   

Abstract

We investigated the phenotype and function of thyroid tumor-, metastatic lymph node-, and peripheral blood-derived T lymphocytes of four patients with papillary thyroid cancer. Both phenotypic analysis of freshly isolated cells and clonal analysis, using a high efficiency cloning technique, were performed. For comparison, intrathyroid and peripheral blood T lymphocytes derived from patients with autoimmune thyroid diseases (Graves' disease and Hashimoto's thyroiditis) have been studied. In papillary cancer, the phenotype of thyroid and lymph node-derived T lymphocytes did not differ from that of peripheral blood lymphocytes of the same patients or lymphocytes from normal peripheral blood. At variance with respect to autoimmune thyroid disease, activation markers were poorly represented. The functional analysis of T cell clones showed similar proportions of interleukin-2-producing (helper-inducer) clones in thyroid, lymph node, and peripheral blood, slightly lower than in Hashimoto's thyroiditis and slightly higher than in Graves' disease. With regard to effector function, we found lower proportion of clones with cytolytic activity in a lectin-dependent assay compared to that in Hashimoto's thyroiditis. Interestingly, however, the proportions of cytolytic clones displaying cytolytic activity against the neoplastic cell line K562 (natural killer-like activity) or fresh unrelated tumor cells (lymphokine-activated killer activity) were relatively high in thyroid cancer infiltrates.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2789232     DOI: 10.1210/jcem-69-4-832

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Myasthenia gravis coincident with papillary thyroid carcinoma: absent expression of the alpha-subunit of the acetylcholine receptor in the tumour.

Authors:  I Illa; N Vila; E Gallardo; F Graus
Journal:  J Neurol       Date:  1995-07       Impact factor: 4.849

2.  Is diffuse and peritumoral lymphocyte infiltration in papillary thyroid cancer a marker of good prognosis?

Authors:  D G P N Villagelin; R B Santos; J H Romaldini
Journal:  J Endocrinol Invest       Date:  2011-07-13       Impact factor: 4.256

3.  The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis.

Authors:  Yeo-Hoon Yoon; Hak Joon Kim; Jin Woo Lee; Jin Man Kim; Bon Seok Koo
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-08-06       Impact factor: 2.503

4.  The effect of methimazole on the immune system is unlikely to operate directly on T lymphocytes.

Authors:  M Bagnasco; D Venuti; G Ciprandi; G Pesce; F Paolieri; G W Canonica
Journal:  J Endocrinol Invest       Date:  1990-06       Impact factor: 4.256

5.  The reliability of fine-needle aspiration biopsy in terms of malignancy in patients with Hashimoto thyroiditis.

Authors:  Murat Kapan; Akin Onder; Sadullah Girgin; Burak Veli Ulger; Ugur Firat; Omer Uslukaya; Abdullah Oguz
Journal:  Int Surg       Date:  2015-02

6.  Papillary thyroid cancer, although strongly associated with lymphocytic infiltration on histology, is only weakly predicted by serum thyroid auto-antibodies in patients with nodular thyroid diseases.

Authors:  E Fiore; T Rago; M Scutari; C Ugolini; A Proietti; G Di Coscio; M A Provenzale; P Berti; L Grasso; S Mariotti; A Pinchera; P Vitti
Journal:  J Endocrinol Invest       Date:  2009-04       Impact factor: 4.256

7.  HLA-D Antigen Expression and Langerhans' Cell Infiltrates in Thyroid Tumors.

Authors:  Simon L. Raphael; Sylvia L. Asa
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

8.  Infiltrating gamma/delta T-cell receptor-positive lymphocytes in Hashimoto's thyroiditis, Graves' disease and papillary thyroid cancer.

Authors:  F Paolieri; C Pronzato; M Battifora; N Fiorino; G W Canonica; M Bagnasco
Journal:  J Endocrinol Invest       Date:  1995-04       Impact factor: 4.256

9.  Coexistence of chronic lymphocytic thyroiditis with papillary thyroid carcinoma: clinical manifestation and prognostic outcome.

Authors:  Jun Soo Jeong; Hyun Ki Kim; Cho-Rok Lee; Seulkee Park; Jae Hyun Park; Sang-Wook Kang; Jong Ju Jeong; Kee-Hyun Nam; Woong Youn Chung; Cheong Soo Park
Journal:  J Korean Med Sci       Date:  2012-07-25       Impact factor: 2.153

Review 10.  The Immune Landscape of Papillary Thyroid Cancer in the Context of Autoimmune Thyroiditis.

Authors:  Fabiana Pani; Paola Caria; Yoshinori Yasuda; Miyara Makoto; Stefano Mariotti; Laurence Leenhardt; Solmaz Roshanmehr; Patrizio Caturegli; Camille Buffet
Journal:  Cancers (Basel)       Date:  2022-09-01       Impact factor: 6.575

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.